More than 8 million people in the U.S. take blood thinners, also called anticoagulants. Many are prescribed the drugs after ...

A new case report was published in Volume 12 of Oncoscience on December 23, 2025, titled "Silent toxicity: A rare case of ...

We’re all just living our lives at the mercy of the almighty algorithm—and if you’re as beauty obsessed as we are, you’ve ...

The patient's symptoms resolved after permanently stopping 5-FU and administering lactulose and intravenous fluids, therefore supporting the ...

A woman in her 60s with a history of atrial fibrillation, hypertension and dyslipidaemia was admitted to the Intensive Care ...

The new U.S. Dietary Guidelines emphasize animal-based protein over plant-based. What are the pros and cons of each? Here’s what the science says.

Mirum Pharmaceuticals, Inc. , a leading rare disease company, today announced that Health Canada has authorized the tablet formulation of LIVMARLI® (maralixibat) for the treatment of cholestatic ...

Moving gemcitabine/nab-paclitaxel to every-other-week dosing decreases infusion visits and may lessen cumulative toxicity, ...

Eli Lilly and Company (NYSE:LLY) Q4 2025 Earnings Call Transcript February 4, 2026 Eli Lilly and Company beats earnings ...

If you’re constantly cold—even when everyone else feels fine—we asked a doctor to help you understand why and what to do next ...

Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a leading rare disease company, today announced that Health Canada has authorized LIVMARLI ® (maralixibat) oral solution and tablet formulation for the ...

Stem cell therapy for dogs is quickly becoming one of the most talked-about advancements in veterinary medicine. As pet owners look for options beyond surgery and long-term medications, regenerative ...